Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of QSAR models for predicting mutagenicity: outcome of the Second Ames/QSAR international challenge project.
Furuhama A, Kitazawa A, Yao J, Matos Dos Santos CE, Rathman J, Yang C, Ribeiro JV, Cross K, Myatt G, Raitano G, Benfenati E, Jeliazkova N, Saiakhov R, Chakravarti S, Foster RS, Bossa C, Battistelli CL, Benigni R, Sawada T, Wasada H, Hashimoto T, Wu M, Barzilay R, Daga PR, Clark RD, Mestres J, Montero A, Gregori-Puigjané E, Petkov P, Ivanova H, Mekenyan O, Matthews S, Guan D, Spicer J, Lui R, Uesawa Y, Kurosaki K, Matsuzaka Y, Sasaki S, Cronin MTD, Belfield SJ, Firman JW, Spînu N, Qiu M, Keca JM, Gini G, Li T, Tong W, Hong H, Liu Z, Igarashi Y, Yamada H, Sugiyama KI, Honma M. Furuhama A, et al. Among authors: ivanova h. SAR QSAR Environ Res. 2023 Oct-Dec;34(12):983-1001. doi: 10.1080/1062936X.2023.2284902. Epub 2023 Dec 4. SAR QSAR Environ Res. 2023. PMID: 38047445
Accounting for data variability, a key factor in in vivo/in vitro relationships: application to the skin sensitization potency (in vivo LLNA versus in vitro DPRA) example.
Dimitrov S, Detroyer A, Piroird C, Gomes C, Eilstein J, Pauloin T, Kuseva C, Ivanova H, Popova I, Karakolev Y, Ringeissen S, Mekenyan O. Dimitrov S, et al. Among authors: ivanova h. J Appl Toxicol. 2016 Dec;36(12):1568-1578. doi: 10.1002/jat.3318. Epub 2016 Apr 15. J Appl Toxicol. 2016. PMID: 27080242
Allosteric cross-talk between the hydrophobic cleft and the BH4 domain of Bcl-2 in control of inositol 1,4,5-trisphosphate receptor activity.
Shapovalov G, Ritaine A, Essonghe NC, de Ridder I, Ivanova H, Karamanou S, Economou A, Bultynck G, Skryma R, Prevarskaya N. Shapovalov G, et al. Among authors: ivanova h. Explor Target Antitumor Ther. 2022;3(3):375-391. doi: 10.37349/etat.2022.00088. Epub 2022 Jun 28. Explor Target Antitumor Ther. 2022. PMID: 36045908 Free PMC article.
Expanding the chemical space of 3(5)-functionalized 1,2,4-triazoles.
Khomenko DM, Doroshchuk RO, Ohorodnik YM, Ivanova HV, Zakharchenko BV, Raspertova IV, Vaschenko OV, Dobrydnev AV, Grygorenko OO, Lampeka RD. Khomenko DM, et al. Among authors: ivanova hv. Chem Heterocycl Compd (N Y). 2022;58(2-3):116-128. doi: 10.1007/s10593-022-03064-z. Epub 2022 Mar 23. Chem Heterocycl Compd (N Y). 2022. PMID: 35340781 Free PMC article.
Bcl-xL acts as an inhibitor of IP3R channels, thereby antagonizing Ca2+-driven apoptosis.
Rosa N, Ivanova H, Wagner LE 2nd, Kale J, La Rovere R, Welkenhuyzen K, Louros N, Karamanou S, Shabardina V, Lemmens I, Vandermarliere E, Hamada K, Ando H, Rousseau F, Schymkowitz J, Tavernier J, Mikoshiba K, Economou A, Andrews DW, Parys JB, Yule DI, Bultynck G. Rosa N, et al. Among authors: ivanova h. Cell Death Differ. 2022 Apr;29(4):788-805. doi: 10.1038/s41418-021-00894-w. Epub 2021 Nov 8. Cell Death Differ. 2022. PMID: 34750538 Free PMC article.
Synthesis of α-substituted 2-(1H-1,2,4-triazol-3-yl)acetates and 5-amino-2,4-dihydro-3H-pyrazol-3-ones via the Pinner strategy.
Khomenko DM, Doroshchuk RO, Ivanova HV, Zakharchenko BV, Raspertova IV, Vaschenko OV, Shova S, Dobrydnev AV, Moroz YS, Grygorenko OO, Lampeka RD. Khomenko DM, et al. Among authors: ivanova hv. Tetrahedron Lett. 2021 Apr 13;69:152956. doi: 10.1016/j.tetlet.2021.152956. Epub 2021 Mar 2. Tetrahedron Lett. 2021. PMID: 35875055 Free PMC article.
33 results